Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0UMVYL |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | n501-alphaHSA |
|||||
| Organization | Fudan University; Hebei Agricultural University. |
|||||
| Synonyms |
n501-alphaHSA
Click to Show/Hide
|
|||||
| Antibody Type | Fusion protein (FP) |
|||||
| Antigen Name | Trophoblast glycoprotein (TPBG) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
n501-alphaHSA-MMAE [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
14.57 nM
|
Moderate 5T4 expression (5T4++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Ovarian mixed germ cell tumor | PA-1 cells | CVCL_0479 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
16.01 nM
|
Moderate 5T4 expression (5T4++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Ovarian serous adenocarcinoma | SKOV-3 cells | CVCL_0532 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
23.5 nM
|
High 5T4 expression (5T4 +++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Invasive breast carcinoma | MCF-7 cells | CVCL_0031 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
41.82 nM
|
High 5T4 expression (5T4 +++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
45.43 nM
|
Moderate 5T4 expression (5T4++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 1000 nM | High 5T4 expression (5T4 +++) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | PANC-1 cells | CVCL_0480 | ||
| Experiment 7 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 1000 nM | Low 5T4 expression (5T4+) | ||
| Method Description |
Cytotoxicity assays performed in the presence of n501-MMAE and n501-alphaHSA-MMAE and their antibody control was assessed using cells plated at 5000 cells per well in medium with in flat bottom 96-well cell culture plates (NEST Biotechnology, China). After 12 h, tumor cells were added with serial dilutions of n501-alphaHSA-MMAE or n501-MMAE in triplicate wells and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. After mixing CCK8 reagent and complete medium at a ratio of 1:9, the cell culture medium was removed and CCK8 working solution was added for another 1-3 h. The absorbance was measured by a microplate reader at 450 nm, and the cell viability ratio (%) was calculated using the following formula: (A sample - A blank)/ (A control - A blank) × 100%.
Click to Show/Hide
|
||||
| In Vitro Model | Normal | FCHO cells | CVCL_U424 | ||
References
